Medicine News and Research

RSS

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

In a recent randomized clinical trial of hospitalized patients with COVID-19 and cardio-metabolic risk factors, the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin did not significantly reduce patients' risk of organ failure, kidney problems, or death compared with placebo, although numerically fewer participants treated with dapagliflozin experienced these outcomes. The findings are published in CJASN.

29 Apr 2022

At US hospitals, a drug mix-up is just a few keystrokes away

More than four years ago, Tennessee nurse RaDonda Vaught typed two letters into a hospital's computerized medication cabinet, selected the wrong drug from the search results, and gave a patient a fatal dose.

29 Apr 2022

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

A recent study demonstrated that the phytochemical curcumin is a potent therapeutic prospect against the SARS-CoV-2 Omicron variant

29 Apr 2022

Improving Medical Communication through Social Media

News-Medical interviews Dr. Benjamin Schmidt about using social media to highlight different perspectives in the medical community and improve communication between patients and doctors.

29 Apr 2022

Autism, ADHD and school absence are associated with increased risk for self- harm in adolescents

Research led by King's College London and South London and Maudsley NHS Foundation Trust has analyzed factors associated with self-harm in over 111,000 adolescents aged 11-17 years old.

29 Apr 2022

Immune fitness plays a vital role in pandemic preparedness

Most of the attempts to curtail the threat of coronavirus disease 2019 (COVID-19) focused on the development of vaccines and the implementation of non-pharmaceutical interventions such as lockdowns and social distancing restrictions to limit the transmission of the disease.

28 Apr 2022

New workflow identifies hidden genetic connections that could improve personalized medicine for IBD

All humans carry genetic variations in their DNA, called Single Nucleotide Polymorphisms (SNPs) that can underlie susceptibility to diseases such as diabetes and cancer.

28 Apr 2022

Genetic bottlenecks could impact Wyoming toads' ability to respond to new pathogens

A new study from North Carolina State University examines immune system diversity in the critically endangered Wyoming toad and finds that genetic bottlenecks could impact a species' ability to respond to new pathogens.

28 Apr 2022

Researchers discover molecular mechanisms underlying extreme need for amino acids in neuroblastoma

Certain childhood tumors have an extreme need for amino acids. Scientists at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the University of Heidelberg, and HI-STEM gGmbH have now discovered the molecular mechanisms underlying this and how the cancer cells could be turned off.

28 Apr 2022

Behavior differences led to higher COVID-19 mortality rates in the southern U.S.

During the pre-Omicron phases of the COVID-19 pandemic, regions of the U.S. had markedly different mortality rates, primarily due to differences in mask use, school attendance, social distancing, and other behaviors.

28 Apr 2022

Specific genes that play important role in schizophrenia identified

Schizophrenia is a serious psychiatric disorder that starts in late adolescence or early adulthood and affects around 1 in 300 people worldwide, according to the World Health Organization.

28 Apr 2022

High-frequency spinal cord stimulation proves to be more effective at improving perceived pain reduction

Spinal cord stimulation (SCS) for chronic pain involves delivering low levels of electricity directly into the spinal cord using an implanted device, which modifies or blocks nerve activity to minimize the sensation of pain reaching the brain.

28 Apr 2022

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Researchers at Ural Federal University have proposed the use of polyoxometallate nanoclusters as a carrier for chemotherapy drug. It will help to deliver medications precisely to the focus of a pathological process, such as a cancerous tumor, without toxic effects on healthy cells.

28 Apr 2022

Researchers develop novel technique to identify relationships among medical concepts

A team of researchers from the Department of Veterans Affairs, Oak Ridge National Laboratory, Harvard's T.H. Chan School of Public Health, Harvard Medical School and Brigham and Women's Hospital has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.

28 Apr 2022

DGP student investigates sexual dysmorphism in mice

Isabella Salamone is an eighth-year student in the Driskill Graduate Program in Life Sciences (DGP) who is studying sexual dysmorphism in mice in the laboratory of Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine.

28 Apr 2022

Scientists identify the neural basis of pleasant touch sensation

Studying mice, scientists at Washington University School of Medicine in St. Louis have identified a neural circuit and a neuropeptide - a chemical messenger that carries signals between nerve cells - that transmit the sensation known as pleasant touch from the skin to the brain.

28 Apr 2022

NIH awards $10.9 million COBRE grant to support Nemours Children's 'well beyond medicine' strategy

The National Institutes of Health (NIH) recently awarded a Phase 1, 5-year $10.9 million Center of Biomedical Research Excellence (COBRE) award, entitled Research Expanding Access to Child Health (REACH) Center to Anne Kazak, PhD, Enterprise Director, and Melissa Alderfer, PhD, Director of the Center for Healthcare and Delivery Science (CHDS) at Nemours Children's Health.

28 Apr 2022

Medicine News and Research

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

At US hospitals, a drug mix-up is just a few keystrokes away

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Improving Medical Communication through Social Media

Autism, ADHD and school absence are associated with increased risk for self- harm in adolescents

Immune fitness plays a vital role in pandemic preparedness

New workflow identifies hidden genetic connections that could improve personalized medicine for IBD

Genetic bottlenecks could impact Wyoming toads' ability to respond to new pathogens

Researchers discover molecular mechanisms underlying extreme need for amino acids in neuroblastoma

Behavior differences led to higher COVID-19 mortality rates in the southern U.S.

Specific genes that play important role in schizophrenia identified

High-frequency spinal cord stimulation proves to be more effective at improving perceived pain reduction

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Researchers develop novel technique to identify relationships among medical concepts

DGP student investigates sexual dysmorphism in mice

Scientists identify the neural basis of pleasant touch sensation

NIH awards $10.9 million COBRE grant to support Nemours Children's 'well beyond medicine' strategy

AI system can enhance images of mouse brain cells in action

New insights into how NANOG protein facilitates the activation of human cell pluripotency

Study finds significant decline in attending adult health care appointments among pediatric transplant patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News